Mutations in the V1 domain of Thai CRF01-AE viruses that confer sensitivity/resistance to broadly neutralizing antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mutations in the V1 domain of Thai CRF01-AE viruses that confer sensitivity/resistance to broadly neutralizing antibodies ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
O'Rourke, S.
- Beteiligte Personen und Organisationen
-
Tatsuno, G.
Yu, B.
Phung, P.
Mesa, K.
To, B.
Limoli, K.
Wrin, T.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P106
- URN
-
urn:nbn:de:1111-2016080725805
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- O'Rourke, S.
- Tatsuno, G.
- Yu, B.
- Phung, P.
- Mesa, K.
- To, B.
- Limoli, K.
- Wrin, T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Broadly Neutralizing Antibodies for HIV Eradication
Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Identification of a novel broadly neutralizing antibody targeting HIV-1
Broadly Neutralizing Antibodies for HIV Eradication
Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Identification of a novel broadly neutralizing antibody targeting HIV-1
Broadly Neutralizing Antibodies for HIV Eradication
Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies